Beneficial effects of prolonged blood pressure control after carotid artery stenting
Anna Chang1, Huei-Fong Hung2, Fang-I Hsieh3
1Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei.
Insights
Carotid artery stenting (CAS) plus medication offers superior long-term blood pressure (BP) control compared to medication alone for severe carotid stenosis. Early post-procedure BP reduction after CAS can predict long-term BP improvements.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Hypertension Management
Background:
- Severe carotid artery stenosis poses a significant risk for stroke and cardiovascular events.
- Effective long-term blood pressure (BP) control is crucial in managing patients with carotid artery stenosis.
- Current treatment strategies often involve medical management alone, with varying degrees of success in BP control.
Purpose of the Study:
- To compare the efficacy of carotid artery stenting (CAS) plus medication versus medication alone in achieving long-term BP control in patients with severe carotid artery stenosis.
- To investigate the correlation between early post-CAS hypotension and subsequent long-term BP reductions.
Main Methods:
- A comparative study involving patients with severe carotid stenosis, divided into CAS plus medication and medication-only groups.
- BP measurements and antihypertensive medication classes were recorded at baseline, 6 months, and 12 months post-intervention.
- Regression analyses were used to assess BP changes and the predictive value of early post-CAS BP reductions on long-term outcomes.
Main Results:
- Patients undergoing CAS plus medication demonstrated significantly greater BP reductions at 6 and 12 months compared to the medication-only group (13.56 mmHg at 6 months, P=0.0002; 16.98 mmHg at 12 months, P<0.0001).
- Significant positive correlations were observed between systolic BP (SBP) reductions within 6 hours post-CAS and SBP reductions at 1 year (β =0.20±0.07, P=0.0067 for mean SBP; β =0.47±0.10, P<0.0001 for maximal SBP).
Conclusions:
- Carotid artery stenting combined with medication offers a significant advantage in long-term BP control at 1 year compared to medical treatment alone for severe carotid stenosis.
- Early reductions in SBP within 6 hours after CAS serve as a potential predictor for sustained BP reduction at 1 year.
Objectives:
The main purpose of this study was to investigate whether carotid artery stenting (CAS) plus medicine in patients with severe carotid artery stenosis provide a better long-term blood pressure (BP) control compared to other medical treatments alone. The other aim was to explore the correlation between post-CAS hypotension within 6 h and long-term BP reductions after CAS.
Materials And Methods:
Patients with severe carotid stenosis were recruited either in the CAS group or in the medication group. BPs and the number of classes of antihypertensive agents were recorded at baseline, 6, and 12 months. Extra BP information was collected at 6 h, 3 days, and 1 month after CAS. Univariate and multivariate linear regressions were performed to test the relationship of BP changes among CAS and medication groups after 6 and 12 months of follow-up. Univariate linear regressions were also used to determine the correlations between the mean or maximal systolic BP (SBP) reductions at 6 h and 1 year post-CAS.
Results:
In total, 72 members in the CAS group and 82 members in the medication group were recruited. Compared with the medication group, patients in the CAS group had greater BP reductions at 6 and 12 months of follow-up after adjusting for confounding factors (13.56 mmHg at 6 months, P=0.0002; 16.98 mmHg at 12 months, P<0.0001). This study also shows significant positive correlations between the mean or maximal SBP reductions 6 h post-CAS and SBP reductions 1 year post-CAS (β =0.20±0.07, P=0.0067 and β =0.47±0.10, P<0.0001, respectively).
Conclusion:
As compared to medical treatment alone, CAS may provide significant beneficial effect on long-term BP control 1 year post-CAS. Furthermore, SBP reductions 6 h post-CAS may predict the SBP reductions 1 year post-CAS.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Assessment of blood pressure in brachial artery(two-step method)
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Peripheral Artery Disease V: Postoperative Nursing Management


